World Biosensors in Medical Diagnostics Market

World Biosensors in Medical Diagnostics Market

This report analyzes the worldwide markets for Biosensors in Medical Diagnostics in Millions of US$. The major product segments analyzed are Medical Biosensors, Glucose Biosensors, Other Medical Biosensors, Environmental Biosensors, and Other Biosensors. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, and Rest of World. Annual forecasts are provided for each region for the period of 2000 through 2015. The report profiles 89 companies including many key and niche players worldwide such as Abbott Point of Care, Inc., Affinity Sensors, Neosensors Limited, Siemens Healthcare Diagnostics Inc., Animas Corp, Lifescan, Inc., Medtronic Diabetes, Roche Diagnostics Ltd., AgaMatrix Inc., Cranfield Health, LifeSensors Inc., M-Biotech, and Nova Biomedical Corp. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

BIOSENSORS IN MEDICAL DIAGNOSTICS MCP-3310
A GLOBAL STRATEGIC BUSINESS REPORT


CONTENTS


I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

Study Reliability And Reporting Limitations I-1
Disclaimers I-2
Data Interpretation & Reporting Level I-2
Quantitative Techniques & Analytics I-3
Product Definitions And Scope Of Study I-3
Medical Biosensors I-4
Glucose Sensors I-4
Other Sensors I-4
Environmental Biosensors I-4
Other Biosensors I-4


II. EXECUTIVE SUMMARY

1. Global Market Overview and Analysis II-1
Commercialization of Biosensors-Challenges Ahead II-1
Facts and General Trends II-1
Regulations Encumber Biosensors Market Growth II-2
Impediments to Commercialization II-2
Global Biosensors Market II-3
Medical Biosensors: A Promising Area II-3
Increasing Medical Applications for Biosensors II-3
Painless Technologies Spark Evolution in Glucose Monitoring
Segment II-3
Biosensors Primarily Used in Blood Gas/Electrolyte
Analyzers, Glucose Meters & Metabolite Analyzers II-4
Swift Growth of Biosensors Demand in Medical Diagnostics II-4
Growing Demand and R&D Activities Drive the Biosensors Market II-4

2. A Retrospective II-5

3. Competitive Scenario II-6
Intensity of Competition II-6

4. Product Overview II-8
About Biosensors II-8
Types of Biosensors II-8
Components of Biosensors II-9
Types of Biosensors II-9
Glucose Sensor II-9
Medical Telesensors II-10
Detecting Cancer and Health Abnormalities II-10
Lactate Sensor II-10
Alcohol Sensor II-11
Biochemical Oxygen Demand Sensor (BOD) II-11
Bioreporters II-11
Miniaturized Devices II-11
Components of Biosensors II-11
Receptor II-11
Transducer II-11
Separator II-11
Biological Components II-12
Attributes of a Good Biosensor II-12
Classes of Biosensors II-12
Potentiometric II-13
Amperometric II-13
Optical Biosensors II-13
Other Physicochemical Biosensors II-13
Methods to Manufacture Optical Biosensors II-13
Simple Fiber Optic Biosensors II-13
Evanescent Wave System II-13
Surface Plasmon Resonance (SPR) II-14

5. Application Areas II-15
A. Medical Applications II-15
Glucose Meters II-15
The Diabetes Monitoring Market II-15
Categorization II-16
Biosensors in Home Glucose Monitors II-16
PBGM Devices: Based on Photometric or Biosensor Technology II-16
Product Innovations Rule the Roost II-17
Non-Invasive Products II-17
Blood Gas Market II-17
Sensors Facilitate Analysis of Blood II-18
Market for DNA Biosensors and Genechips in Nascent Stage II-18
B. Environmental Biosensors II-19
C. Industrial Applications II-20
Summarization of Available Biosensors & Technological
Applications II-20
D. Other Application Areas II-21
Biological Warfare- An Increasingly Important Area for
Biosensors II-21
Fingerprinting- A Much Needed Advantage? II-21

6. Product Launches/Innovations II-22
WaveSense Europe Unveils New Jazz™ Blood Glucose Meter in UK II-22
Mexico Inventors Develop Integrated Optical Biosensor System II-22
New Biosensor Detects Avian Influenza Virus II-22
US Scientists to Develop Nano-based Biosensor II-22
Japanese Inventors Develop New Biosensor II-22
US Scientists Develops New Biosensor II-22
NeoSensors Re-Introduces Biosensor Product Range II-23
Siemens Medical Releases Rapidlab Version 2.0 Software II-23
Innovative Biosensors Unveils BioFlash Biological Detector II-23
Medtronic Introduces Guardian® Real-Time System for Diabetes
Management II-23
Nova Biomedical Introduces Nova Max™ Blood Glucose Monitor II-24
ARKRAY Introduces PocketChem EZ Blood Glucose Monitoring Device II-24
Medtronic Unveils Continuous Glucose Monitoring System II-24
Abbott Introduces FreeStyle Lite II-24
SPO Medical Launches Two Oximetry Devices II-24
ForteBio Launches New Biosensors for Research and Development II-25
Axela Biosensors Unveils dotLab™ System II-25
California Inventor Develops Anti Inflammatory Biosensor II-25
Japanese Inventors Develop Measuring System for Biosensor II-25
Biophage Develops New Biosensor II-25
AMBRI Develops New Influenza Biosensor II-26
LifeScan Unveils OneTouch® UltraMini™ Blood Glucose
Monitoring System II-26
Akubio Introduces RAP•d 4 Biomolecular Interactions Analysis
System II-26
Bio-Rad Launches ProteOn XPR36 Protein Interaction Array System II-26
Exmovere Introduces Bluetooth-Enabled Biosensor Wristwatch II-27
SPO Medical Unveils Compact Oximetry System, PulseOx 7500™ II-27
Panasonic Introduces Multi-Task Biosensor for Disease Detection II-27
Medtronic Launches Glucose Monitoring System in India II-28
ForteBio Introduces New Biosensors for Octet System II-28

7. Recent Industry Activity II-29
Medtronic Receives FDA Clearance on OneTouch® U ltralink™ II-29
Medtronic Bags FDA Approval on CGMS® iPro™ II-29
T+ Medical Partners LifeScan for Diabetes Management II-29
Aerotel Medical Systems Takes Over Tadiran LifeCare’s
Business Operations II-30
Siemens Medical Completes Acquisition of Bayer’s Diagnostic
Division II-30
Biosensors to Purchase 50% Stake in JWMS II-30
Siemens Signs Merger Agreement with Dade Behring II-30
Abbott to Divest Core Laboratory Diagnostics Business II-31
Axela and BioCheck Inks License and Supply Agreement II-31
FDA Grants Waiver for Abbott’s i-STAT CHEM8+ II-31
Aventir Receives FDA Approval for GlucosePilot™ II-31
Inscent to Develop New Biosensor to Save Public Health II-32
Wellion® Linus Receives TNO Approval II-32
Virogenomics Receives Grant of US$1.9M to Develop BioSensor
Technology II-32
Acacia Acquires Rights to Patent for Pointing Device Technology II-32
NanoSensors Grants Sub-Contract for Prototype Production of
Biosensor II-32
Axela and Toronto University to Develop Patient Bedside
Testing Devices II-32
Attana and Isogen Ink a Distribution Agreement II-33
Biosense Webster Expands Alliance with Stereotaxis II-33
Medtronic Enters into Exclusive Distribution Agreement with
LifeScan II-33
WaveSense to Launch European Subsidiary, WaveSense Europe II-34
MedMira Acquires SensorChem II-34
Siemens Acquires Diagnostic Products Corporation II-34
Farfield Group Acquires Biosensor Operations of Thermo Electron II-35
Kimberly-Clark Acquires Stake in Axela Biosensors II-35
Bionas and Primacyt Co-operates to Develop Cell-Based Assay II-35
Biosensors Japan Co. to Sell Stents in Japan II-35
Isis Receives Copyright for Pathogen Identification Methodology II-35
Micronics Issues Patent License to Cleveland II-36
Medtronic Receives US FDA Approval on New CGM System II-36
AgaMatrix Bags FDA Approval to Market Wave 1™ II-36
BRI to Acquire Lumera’s Biosensor Instrument II-36
Bruker Daltonics Enters into Strategic Alliance with Isis
Pharmaceuticals II-36
NeuroMetrix Inks Manufacturing Agreement with Parlex USA II-37
Synthetic Blood International Enters into Strategic Alliance
With UTEK II-37
EPSRC Enters Joint Research Agreement with Philips II-37
Biophage Pharma Enters Agreement with Biosensor Systems II-37
Axis Participates in Biosensor Platform Development Project II-37
US Genomics Bags Biosensor Contract from DHS II-38
Bio-Nano Sensium Files Patent Application for Wireless
Biosensors II-38
SPO Medical Completes Reverse Acquisition of United Diagnostic II-38
Biophage Pharma Develops New Technology to Detect Bacteria II-38
Cygnus Turns to Liquidation II-38
TGC Research Acquires Certain Assets of Diametrics II-39
Diametrics Restructures II-39
Abbott Acquires I-Stat II-39
Seahawk Contracts with In-Q-Tel II-39
Pinnacle Signs an Agreement with Primetech II-39
RoboDesign Enters into an Agreement with Isis II-39
Theron Enters into a Licensing Agreement II-40
Innovative Biosensors Enters Licensing Agreement with MIT II-40
Biosensors International and X-Cell Medical Mutually Agree to
Form a New Company II-40
Biosensors International Private Ltd. Divests Stent System to
Guidant Corporation II-40
Medtronic Acquires MiniMed, Inc. and Medical Research Group,
Inc. II-40
Virtek Vision Acquires FONA Diagnostics II-41
Dow Corning Strategically Alliances with Genencor II-41
Synthetic Blood International Obtains Patent II-41
Prolinx Forges an Agreement with Texas Instruments II-42
Kumetrix Bags SBIR Contract from NIDDK II-42
Standard MEMS Forms BioMEMS Technology Group II-42

8. Technological Developments II-43
Holograms – The Next Generation Biosensors .. II-43
Smart Bandages– A New Way of Wound Care II-43
PulseTracer Unveils PT100 Biosensor II-43
Molecular Biology- Increasingly Used in the Biosensor Business II-43
Micro-System Platforms for Biosensor Applications II-44
Microelectromechanical Systems- Creating New Horizons II-44
Biochips: Increasingly Being Used in Point-Of-Care Devices II-44
Implantable Biosensors: A Possibility in the Near Future II-45
Biosensors to Carry Out Medical-Checkups at Home II-45
Immunosensors to Enhance Current Immunoassay Techniques II-45
Microfluidic Glucose Sensor II-45
Biosensors in Mycotoxin Detection II-46
Some Major Technological Developments in Recent Years II-46
Animas into Development of Implantable Sensors for Blood
Glucose II-46
Cytoplex Develops Biosensor II-46
Immunosensor Ricin Detector II-47
Biosensor to Identify Viruses Electronically II-47
Electrochemical Array Biosensor Technology II-47
Polymer-Coated Microheaters Enters Market II-47
Technology Archive II-47
UCSD Instrumental in the Development of Polymer-based,
Nanoscale Biosensors II-47
Applied Digital Solutions Launches VeriChip™ II-48
Applied Digital Solutions, Inc. Incorporates Biosensors
Technology in New Device II-48
University of Rhode Island Develops Biosensor to Detect
Pathological Bacteria in Foods II-48
Cellomics Launches the Development of Biowarfare Detection II-48
Biosensors- Speed Pathogen Detection II-49
Optic Interferometic Sensor for Detecting Biological Hazards
and Attacks II-49
Digital Signal Processing Technology (DSP) in Biosensors II-50
The World’s Smallest Biosensors II-50
MiniMed Gains FDA Approval for Its Subcutaneous Glucose Sensor II-50
The Nanomachine: The World’s Smallest Machine II-51
Knoxville Cancer Survival Center Develops Laser-based Sensor II-51
Genetic Engineering Creates Biosensors to Clean Environment II-51
New Horizons Develops Immunoassay Tests II-52
John Hopkins University Develops New Alfa-Toxin Fab II-52
Texas Instruments Develops a New Surface Plasmon Resonance
Sensor II-52
A New Biosensor to Confirm Pregnancy II-52
Gold Biosensor to Detect Carcinogens II-53
Drug Detecting Biosensor II-53
Functional Genomics Technology Uses Biosensors II-53

9. Focus on Select Players II-54
Companies Developing Biosensor-Based Devices II-54
Abbott Point of Care, Inc. (USA) II-54
Affinity Sensors (USA) II-54
Neosensors Limited (UK) II-54
Siemens Healthcare Diagnostics Inc (USA) II-54
Animas Corp (US) II-54
Lifescan, Inc. (USA) II-55
Medtronic Diabetes (USA) II-55
Roche Diagnostics Ltd. (USA) II-55
Leading Developers of Biosensor Technology II-55
AgaMatrix Inc. (USA) II-55
Cranfield Health (UK) II-56
LifeSensors INC. (USA) II-56
M-Biotech (USA) II-56
Nova Biomedical Corp. (USA) II-56

10. Global Market Perspective II-58
Table 1: World Recent Past, Current & Future Market Analysis
for Biosensors by Geographic Region – US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan) and Rest of World
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) II-58

Table 2: World Long-term Projections for Biosensors by
Geographic Region – US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2011 through 2015 (includes corresponding Graph/Chart) II-59

Table 3: World 10-Year Perspective for Biosensors by
Geographic Region – Percentage Breakdown of Value Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and
Rest of World Markets for Years 2003, 2008 & 2012 (includes
corresponding Graph/Chart) II-60

Table 4: World Recent Past, Current & Future Market Analysis
for Medical Biosensors by Geographic Region – US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan) and Rest of
World Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) II-61

Table 5: World Recent Past, Current & Future Market Analysis
for Medical Biosensors by Product Segments- Glucose Biosensors
and Other Medical Biosensors Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2000 through
2010) (includes corresponding Graph/Chart) II-62

Table 6: World Long-term Projections for Medical Biosensors by
Geographic Region – US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2011 through 2015 (includes corresponding Graph/Chart) II-63

Table 7: World Long-term Projections for Medical Biosensors by
Product Segment - Glucose Biosensors and Other Medical
Biosensors Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2011 through 2015 (includes
corresponding Graph/Chart) II-64

Table 8: World 10-Year Perspective for Medical Biosensors by
Geographic Region – Percentage Breakdown of Value Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and
Rest of World Markets for Years 2003, 2008 & 2012 (includes
corresponding Graph/Chart) II-65

Table 9: World 10-Year Perspective for Medical Biosensors by
Product Segment– Percentage Breakdown of Value Sales for
Glucose Biosensors and Other Medical Biosensors Markets for
Years 2003, 2008 & 2012 II-65

Table 10: World Recent Past, Current & Future Market Analysis
for Glucose Biosensors by Geographic Region – US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan) and Rest of
World Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) II-66

Table 11: World Long-term Projections for Glucose Biosensors
by Geographic Region – US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) II-67

Table 12: World 10-Year Perspective for Glucose Biosensor by
Geographic Region – Percentage Breakdown of Value Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and
Rest of World Markets for Years 2003, 2008 & 2012 (includes
corresponding Graph/Chart) II-68

Table 13: World Recent Past, Current & Future Market Analysis
for Other Medical Biosensors by Geographic Region – US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest
of World Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) II-69

Table 14: World Long-term Projections for Other Medical
Biosensors by Geographic Region – US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) II-70

Table 15: World 10-Year Perspective for Other Medical
Biosensor by Geographic Region – Percentage Breakdown of
Value Sales for US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan) and Rest of World Markets for Years 2003,
2008 & 2012 (includes corresponding Graph/Chart) II-71

Table 16: World Recent Past, Current & Future Market Analysis
for Environmental Biosensors by Geographic Region – US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan) and Rest
of World Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) II-72

Table 17: World Long-term Projections for Environmental
Biosensors by Geographic Region – US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), and Rest of World Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2011 through 2015 (includes corresponding
Graph/Chart) II-73

Table 18: World 10-Year Perspective for Environmental
Biosensor by Geographic Region – Percentage Breakdown of
Value Sales for US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan) and Rest of World Markets for Years 2003,
2008 & 2012. (includes corresponding Graph/Chart) II-74

Table 19: World Recent Past, Current & Future Market Analysis
for Other Biosensors by Geographic Region – US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan) and Rest of World
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) II-75

Table 20: World Long-term Projections for Other Biosensors by
Geographic Region – US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), and Rest of World Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2011 through 2015 (includes corresponding Graph/Chart) II-76

Table 21: World 10-Year Perspective for Other Biosensor by
Geographic Region – Percentage Breakdown of Value Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan) and
Rest of World Markets for Years 2003, 2008 & 2012 (includes
corresponding Graph/Chart) II-77


III. MARKET

1. The United States III-1
A.Market Analysis III-1
Other Facts and Figures III-1
The US Diabetes Monitoring Market III-1
Biosensors- Speeding Pathogen Detection III-1
Product Launches/Innovations III-2
Strategic Corporate Developments III-9
Focus on Select Key Players III-17
Companies Developing Biosensor-Based Devices III-17
Abbott Point Of Care, Inc. III-17
Affinity Sensors III-17
Animas Corporation III-17
Siemens Healthcare Diagnostics Inc III-17
LifeScan III-18
Medtronic Diabetes III-18
Roche Diagnostics Ltd. III-18
Leading Developers of Biosensor Technology III-18
AgaMatrix Inc. III-18
LifeSensors Inc. III-19
M-Biotech III-19
Nova Biomedical Corp. III-19
B.Market Analytics III-20
Table 22: US Recent Past, Current & Future Market Analysis
for Biosensors by Product Segment – Medical Biosensors
(Glucose Biosensors and Other Medical Biosensors),
Environmental Biosensors and Other Biosensors Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-20

Table 23: US Long-term Projections for Biosensors by Product
Segment – Medical Biosensors (Glucose Biosensors and Other
Medical Biosensors), Environmental Biosensors and Other
Biosensors Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2011 through 2015
(includes corresponding Graph/Chart) III-20

Table 24: US 10-Year Perspective for Biosensors by Product
Segment – Percentage Breakdown of Value Sales for Medical
Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for 2003, 2008 & 2012 (includes corresponding
Graph/Chart) III-21

2. Canada III-22
A.Market Analysis III-22
Biosensor Researches in Canada III-22
Microfluidic Systems III-22
Biosensor Institutions III-22
Strategic Corporate Developments III-22
Product Launches III-23
B.Market Analytics III-24
Table 25: Canadian Recent Past, Current & Future Market
Analysis for Biosensors by Product Segment – Medical
Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) III-24

Table 26: Canadian Long-term Projections for Biosensors by
Product Segment – Medical Biosensors (Glucose Biosensors and
Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2011 through 2015
(includes corresponding Graph/Chart) III-25

Table 27: Canadian 10-Year Perspective for Biosensors by
Product Segment – Percentage Breakdown of Value Sales for
Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for 2003, 2008 & 2012 (includes corresponding
Graph/Chart) III-25

3. Japan III-26
A.Market Analysis III-26
Product Launches/Innovations III-26
Strategic Corporate Developments III-27
B.Market Analytics III-28
Table 28: Japanese Recent Past, Current & Future Market
Analysis for Biosensors by Product Segment – Medical
Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) III-28

Table 29: Japanese Long-term Projections for Biosensors by
Product Segment – Medical Biosensors (Glucose Biosensors and
Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2011 through 2015
(includes corresponding Graph/Chart) III-29

Table 30: Japanese 10-Year Perspective for Biosensors by
Product Segment – Percentage Breakdown of Value Sales for
Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for 2003, 2008 & 2012 (includes corresponding
Graph/Chart) III-29

4. Europe III-30
A.Market Analysis III-30
Market Trends & Issues III-30
Environmental Monitoring Diffusing in the European Countries III-30
B.Market Analytics III-31
Table 31: European Recent Past, Current & Future Market
Analysis for Biosensors by Geographic Region – France,
Germany, Italy, UK & Rest of Europe Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2000 through 2010 (includes corresponding Graph/Chart) III-31

Table 32: European Recent Past, Current & Future Market
Analysis for Biosensors by Product Segment – Medical
Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) III-31

Table 33: European Long-term Projections for Biosensors by
Geographic Region – France, Germany, Italy, UK, and Rest of
Europe Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2011 through 2015
(includes corresponding Graph/Chart) III-32

Table 34: European Long-term Projections for Biosensors by
Product Segment – Medical Biosensors (Glucose Biosensors and
Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2011 through 2015
(includes corresponding Graph/Chart) III-32

Table 35: European 10-Year Perspective for Biosensors by
Geographic Region – Percentage Breakdown of Value Sales for
France, Germany, Italy, UK & Rest of Europe Markets for
Years 2003, 2008 & 2012 (includes corresponding
Graph/Chart) III-33

Table 36: European 10-Year Perspective for Biosensors by
Product Segment – Percentage Breakdown of Value Sales for
Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for 2003, 2008 & 2012 (includes corresponding
Graph/Chart) III-33

4a. France III-34
Market Analysis III-34
Table 37: French Recent Past, Current & Future Market
Analysis for Biosensors by Product Segment – Medical
Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) III-34

Table 38: French Long-term Projections for Biosensors by
Product Segment – Medical Biosensors (Glucose Biosensors and
Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2011 through 2015
(includes corresponding Graph/Chart) III-35

Table 39: French 10-Year Perspective for Biosensors by
Product Segment – Percentage Breakdown of Value Sales for
Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for 2003, 2008 & 2012 (includes corresponding
Graph/Chart) III-35

4b. Germany III-36
A.Market Analysis III-36
Strategic Corporate Developments III-36
B.Market Analytics III-37
Table 40: German Recent Past, Current & Future Market
Analysis for Biosensors by Product Segment – Medical
Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) III-37

Table 41: German Long-term Projections for Biosensors by
Product Segment – Medical Biosensors (Glucose Biosensors and
Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2011 through 2015
(includes corresponding Graph/Chart) III-38

Table 42: German 10-Year Perspective for Biosensors by
Product Segment – Percentage Breakdown of Value Sales for
Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for 2003, 2008 & 2012 (includes corresponding
Graph/Chart) III-38

4c. Italy III-39
Market Analysis III-39
Table 43: Italian Recent Past, Current & Future Market
Analysis for Biosensors by Product Segment – Medical
Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets Independently Analyzed with Annual Sales Figures
in US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) III-39

Table 44: Italian Long-term Projections for Biosensors by
Product Segment – Medical Biosensors (Glucose Biosensors and
Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2011 through 2015
(includes corresponding Graph/Chart) III-40

Table 45: Italian 10-Year Perspective for Biosensors by
Product Segment – Percentage Breakdown of Value Sales for
Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for 2003, 2008 & 2012 (includes corresponding
Graph/Chart) III-40

4d. The United Kingdom III-41
A.Market Analysis III-41
Outlook of Industrial Biosensors III-41
Key Players III-41
Cranfield Health III-41
Neosensors Limited III-41
Product Launches/Innovations III-42
Strategic Corporate Developments III-42
B.Market Analytics III-44
Table 46: UK Recent Past, Current & Future Market Analysis
for Biosensors by Product Segment – Medical Biosensors
(Glucose Biosensors and Other Medical Biosensors),
Environmental Biosensors and Other Biosensors Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2010 (includes corresponding
Graph/Chart) III-44

Table 47: UK Long-term Projections for Biosensors by
Product Segment – Medical Biosensors (Glucose Biosensors
and Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2011 through 2015
(includes corresponding Graph/Chart) III-45

Table 48: UK 10-Year Perspective for Biosensors by Product
Segment – Percentage Breakdown of Value Sales for Medical
Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for 2003, 2008 & 2012 (includes corresponding
Graph/Chart) III-45

4e. Rest of Europe III-46
A.Market Analysis III-46
Strategic Corporate Developments III-46
B.Market Analytics III-47
Table 49: Rest of Europe Market for Biosensors – Recent
Past, Current & Future Analysis by Product Segment for
Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) III-47

Table 50: Rest of Europe Long-term Projections for
Biosensors by Product Segment – Medical Biosensors (Glucose
Biosensors and Other Medical Biosensors), Environmental
Biosensors and Other Biosensors Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2011 through 2015 (includes corresponding Graph/Chart) III-48

Table 51: Rest of Europe 10-Year Perspective for Biosensors
by Product Segment – Percentage Breakdown of Value Sales
for Medical Biosensors (Glucose Biosensors and Other
Medical Biosensors), Environmental Biosensors and Other
Biosensors Markets for 2003, 2008 & 2012 (includes
corresponding Graph/Chart) III-49

5. Asia-Pacific III-50
A.Market Analysis III-50
Strategic Development III-50
Product Launch III-50
Historic Review III-50
CFTRI of India Announces New Biosensor III-50
CRC Develops an Extremely High Sensor III-50
Nanomachine Developed in Australia III-51
B.Market Analytics III-51
Table 52: Asia Pacific Market for Biosensors – Recent
Past, Current & Future Analysis by Product Segment for
Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) III-51

Table 53: Asia-Pacific Long-term Projections for Biosensors
by Product Segment – Medical Biosensors (Glucose Biosensors
and Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2011 through 2015
(includes corresponding Graph/Chart) III-52

Table 54: Asia Pacific 10-Year Perspective for Biosensors by
Product Segment – Percentage Breakdown of Value Sales for
Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for 2003, 2008 & 2012 (includes corresponding
Graph/Chart) III-53

6. Rest of World III-54
A.Market Analysis III-54
Strategic Corporate Development III-54
B.Market Analytics III-55
Table 55: Rest of World Market for Biosensors - Recent Past,
Current & Future Analysis by Product Segment for Medical
Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2000 through 2010 (includes
corresponding Graph/Chart) III-55

Table 56: Rest of World Long-term Projections for Biosensors
by Product Segment - Medical Biosensors (Glucose Biosensors
and Other Medical Biosensors), Environmental Biosensors and
Other Biosensors Markets Independently Analyzed with Annual
Sales Figures in US$ Million for Years 2011 through 2015
(includes corresponding Graph/Chart) III-56

Table 57: Rest of World 10-Year Perspective for Biosensors
by Product Segment - Percentage Breakdown of Value Sales
for Medical Biosensors (Glucose Biosensors and Other Medical
Biosensors), Environmental Biosensors and Other Biosensors
Markets for 2003, 2008 & 2012 (includes corresponding
Graph/Chart) III-57


IV. COMPETITIVE LANDSCAPE